Abbott Laboratories buy Benchmark Co.
Start price
10.10.25
/
50%
€115.06
Target price
10.10.26
€125.35
Performance (%)
-20.30%
Price
31.07.26
€91.70
Summary
This prediction is currently active. The price of Abbott Laboratories has decreased since the start of the prediction. Compared to the start price this results in a performance of -20.30%. This prediction currently runs until 10.10.26. The prediction end date can be changed by Benchmark_Co_ at any time. Benchmark_Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Abbott Laboratories | 1.103% | 1.103% |
| iShares Core DAX® | 2.591% | 2.691% |
| iShares Nasdaq 100 | -0.915% | -7.368% |
| iShares Nikkei 225® | 0.145% | -10.196% |
| iShares S&P 500 | -0.367% | -0.833% |
Comments by Benchmark_Co_ for this prediction
In the thread Discuss Abbott Laboratories
Abbott Laboratories (NYSE:ABT) is now covered by analysts at Benchmark Co.. They set a "buy" rating and a $145.00 price target on the stock.
Ratings data for ABT provided by MarketBeat
Stopped prediction by Benchmark_Co_ for Abbott Laboratories
Abbott Laboratories
Start price
Target price
Perf. (%)
€81.24
17.04.26
17.04.26
€101.90
17.04.27
17.04.27
12.88%
31.07.26
31.07.26
